TABLE 1.

Characteristics of LBD cases

Variable	Summary (N = 585)
Age at death (years)	79 (50, 99)
Sex (men)	345 (59.0%)
Braak NFT stage
0	13 (2.2%)
I	20 (3.4%)
II	99 (16.9%)
III	148 (25.3%)
IV	92 (15.7%)
V	94 (16.1%)
VI	119 (20.3%)
Thal amyloid phase
0	61 (11.2%)
1	51 (9.4%)
2	27 (5.0%)
3	112 (20.6%)
4	46 (8.4%)
5	248 (45.5%)
LBD subtype
Brainstem	72 (12.3%)
Transitional	208 (35.6%)
Diffuse	305 (52.1%)
Lewy body counts
Middle frontal gyrus	3 (0, 35)
Superior temporal gyrus	7 (0, 50)
Inferior parietal gyrus	2 (0, 30)
Cingulate gyrus	8 (0, 35)
Parahippocampal gyrus	14 (0, 45)
Putaminal TH-ir
Dorsolateral	4.26 (0.26, 42.18)
Ventromedial	9.99 (0.26, 39.18)
Substantia nigra neuronal loss score
Ventrolateral
0 = none	3 (0.6%)
0.5 = none/mild	10 (2.1%)
1 = mild	56 (11.8%)
1.5 = mild/moderate	55 (11.6%)
2 = moderate	61 (12.9%)
2.5 = moderate/severe	55 (11.6%)
3 = severe	233 (49.3%)
Medial
0 = none	24 (5.4%)
0.5 = none/mild	26 (5.8%)
1 = mild	83 (18.6%)
1.5 = mild/moderate	53 (11.9%)
2 = moderate	56 (12.6%)
2.5 = moderate/severe	54 (12.1%)
3 = severe	150 (33.6%)

The sample median (minimum, maximum) is given for continuous variables. Information was unavailable for Thal amyloid phase (N = 40), Lewy body counts in the middle frontal (N = 20), superior temporal (N = 21), inferior parietal (N = 21), cingulate (N = 27), and parahippocampal (N = 88) gyri, dorsolateral putaminal TH-ir (N = 107), ventromedial putaminal TH-ir (N = 107), ventrolateral SN neuronal loss score (N = 112), and medial SN neuronal loss score (N = 139).